Virtual Medicinal Product (VMP)
-
Idarucizumab 2.5g/50ml solution for infusion vials
Name Details
|
Current Name
Idarucizumab 2.5g/50ml solution for infusion vials
|
Start Date
17-12-2015
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 50.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous, solutioninjection.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
V03AB37
| BNF |
|
Current BNF
02080400
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
02080400
|
Start Date
20-02-2017
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 31141811000001100 |
17-12-2015 |
|
VMP Ingredients
VMP ingredients table
| Idarucizumab |
Based on Ingredient Substance |
|
50 mg |
1 ml |
Name
Idarucizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Idarucizumab
-
VMP
(Current) Idarucizumab 2.5g/50ml solution for ...
Virtual Medicinal Product Pack (VMPP) Information